Cargando…
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor
The recent 2014–2016 West African Ebola virus epidemic underscores the need for the development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus infections and the lack of FDA-approved vaccine or therapy that is available for the prevention and treatment. Traditional...
Autores principales: | Cui, Qinghua, Du, Ruikun, Anantpadma, Manu, Schafer, Adam, Hou, Lin, Tian, Jingzhen, Davey, Robert A., Cheng, Han, Rong, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923446/ https://www.ncbi.nlm.nih.gov/pubmed/29584652 http://dx.doi.org/10.3390/v10040152 |
Ejemplares similares
-
Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus
por: Cui, Qinghua, et al.
Publicado: (2018) -
Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases
por: Chen, Yingqing, et al.
Publicado: (2022) -
Rhodiola rosea Reduces Intercellular Signaling in Campylobacter jejuni
por: Kunčič, Ajda, et al.
Publicado: (2022) -
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019) -
Evaluation of Phenol-Substituted Diphyllin Derivatives
as Selective Antagonists for
Ebola Virus Entry
por: Plescia, Caroline B., et al.
Publicado: (2022)